Global Osteoarthritis Pain Drugs Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Executive Summary
According to GRD Survey data, the global Osteoarthritis Pain Drugs market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Osteoarthritis Pain Drugs market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Osteoarthritis Pain Drugs in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Oral
Injection
External
Market Snapshot, By Application
Medical Care
Personal Care
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
Zhejiang Chengyi Pharmaceutical
TEVA
Taisho Pharmaceutical
SK Chemicals
Sino Biopharmaceutical
Seikagaku Corporation
Sanofi
Pfizer
Mylan
Mikasa Seiyaku
Lilly
Johnson & Johnson
Jingfeng Pharmaceutical
Iroko Pharmaceuticals
Haohai Biological
GSK
GlaxoSmithKline
Freda
Crystal Genomics
Chugai Pharmaceutical
Bright Future
Bayer
Almatica Pharma
Abbott Laboratories
The study objectives of this report are:
To study and analyze the global Osteoarthritis Pain Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Osteoarthritis Pain Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Osteoarthritis Pain Drugs manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Osteoarthritis Pain Drugs market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Osteoarthritis Pain Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Osteoarthritis Pain Drugs are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Osteoarthritis Pain Drugs Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Osteoarthritis Pain Drugs Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Osteoarthritis Pain Drugs
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Osteoarthritis Pain Drugs Sales Channel and Distributors Analysis
3.3.1 Osteoarthritis Pain Drugs Sales Channel
3.3.2 Osteoarthritis Pain Drugs Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Osteoarthritis Pain Drugs Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Osteoarthritis Pain Drugs Type Introduction
4.1.1 Oral
4.1.2 Injection
4.1.3 External
4.2 Global Osteoarthritis Pain Drugs Sales by Type 2016-2021
4.3 Global Osteoarthritis Pain Drugs Revenue by Type 2016-2021
4.4 Global Osteoarthritis Pain Drugs Price by Type 2016-2021
5 Market Segment: by Application
5.1 Osteoarthritis Pain Drugs Type Introduction
5.1.1 Medical Care
5.1.2 Personal Care
5.2 Global Osteoarthritis Pain Drugs Sales by Application 2016-2021
5.3 Global Osteoarthritis Pain Drugs Revenue by Application 2016-2021
5.4 Global Osteoarthritis Pain Drugs Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Osteoarthritis Pain Drugs Market by Region
6.1.1 Global Osteoarthritis Pain Drugs Sales by Regions
6.1.2 Global Osteoarthritis Pain Drugs Revenue by Regions
6.2 North America Osteoarthritis Pain Drugs Market 2016-2021
6.3 Europe Osteoarthritis Pain Drugs Market 2016-2021
6.4 Asia Pacific Osteoarthritis Pain Drugs Market 2016-2021
6.5 South America Osteoarthritis Pain Drugs Market 2016-2021
6.6 Middle East and Africa Osteoarthritis Pain Drugs Market 2016-2021
7 North America
7.1 North America Osteoarthritis Pain Drugs Market by Country 2016-2021
7.1.1 North America Osteoarthritis Pain Drugs Sales by Country
7.1.2 North America Osteoarthritis Pain Drugs Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Osteoarthritis Pain Drugs Market by Country 2016-2021
8.1.1 Europe Osteoarthritis Pain Drugs Sales by Country
8.1.2 Europe Osteoarthritis Pain Drugs Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Osteoarthritis Pain Drugs Market by Country 2016-2021
9.1.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Country
9.1.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Osteoarthritis Pain Drugs Market by Country 2016-2021
10.1.1 South America Osteoarthritis Pain Drugs Sales by Country
10.1.2 South America Osteoarthritis Pain Drugs Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Osteoarthritis Pain Drugs Market by Country 2016-2021
11.1.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Country
11.1.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Zhejiang Chengyi Pharmaceutical
12.1.1 Zhejiang Chengyi Pharmaceutical Company Information
12.1.2 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.1.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Zhejiang Chengyi Pharmaceutical Key Development
12.2 TEVA
12.2.1 TEVA Company Information
12.2.2 TEVA Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.2.3 TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 TEVA Key Development
12.3 Taisho Pharmaceutical
12.3.1 Taisho Pharmaceutical Company Information
12.3.2 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.3.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Taisho Pharmaceutical Key Development
12.4 SK Chemicals
12.4.1 SK Chemicals Company Information
12.4.2 SK Chemicals Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.4.3 SK Chemicals Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 SK Chemicals Key Development
12.5 Sino Biopharmaceutical
12.5.1 Sino Biopharmaceutical Company Information
12.5.2 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.5.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Sino Biopharmaceutical Key Development
12.6 Seikagaku Corporation
12.6.1 Seikagaku Corporation Company Information
12.6.2 Seikagaku Corporation Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.6.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Seikagaku Corporation Key Development
12.7 Sanofi
12.7.1 Sanofi Company Information
12.7.2 Sanofi Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.7.3 Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Seikagaku Corporation Key Development
12.9 Mylan
12.9.1 Mylan Company Information
12.9.2 Mylan Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.9.3 Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Mylan Key Development
12.8 Pfizer
12.8.1 Pfizer Company Information
12.8.2 Pfizer Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.8.3 Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Pfizer Key Development
12.11 Lilly
12.11.1 Lilly Company Information
12.11.2 Lilly Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.11.3 Lilly Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Lilly Key Development
12.12 Johnson & Johnson
12.12.1 Johnson & Johnson Company Information
12.12.2 Johnson & Johnson Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.12.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Johnson & Johnson Key Development
12.13 Jingfeng Pharmaceutical
12.13.1 Jingfeng Pharmaceutical Company Information
12.13.2 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.13.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 Jingfeng Pharmaceutical Key Development
12.14 Iroko Pharmaceuticals
12.14.1 Iroko Pharmaceuticals Company Information
12.14.2 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.14.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Iroko Pharmaceuticals Key Development
12.15 Haohai Biological
12.15.1 Haohai Biological Company Information
12.15.2 Haohai Biological Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
12.15.3 Haohai Biological Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Haohai Biological Key Development
12.17 GlaxoSmithKline
12.18 Freda
12.19 Crystal Genomics
12.20 Chugai Pharmaceutical
12.21 Bright Future
12.22 Bayer
12.23 Almatica Pharma
12.24 Abbott Laboratories
13 Global Osteoarthritis Pain Drugs Market Forecast by Region by Type and by Application
13.1 Global Osteoarthritis Pain Drugs Sales, Revenue Forecast 2022-2027
13.2 Global Osteoarthritis Pain Drugs Forecast by Regions
13.2.1 Global Osteoarthritis Pain Drugs Sales Forecast by Region 2022-2027
13.2.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Region 2022-2027
13.3 Global Osteoarthritis Pain Drugs Forecast by Type
13.3.1 Global Osteoarthritis Pain Drugs Sales Forecast by Type 2022-2027
13.3.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Type 2022-2027
13.3.3 Global Osteoarthritis Pain Drugs Price Forecast by Type 2022-2027
13.4 Global Osteoarthritis Pain Drugs Forecast by Application
13.4.1 Global Osteoarthritis Pain Drugs Sales Forecast by Application 2022-2027
13.4.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Application 2022-2027
13.4.3 Global Osteoarthritis Pain Drugs Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
List of Tables
Table 1: Global Osteoarthritis Pain Drugs Production Specifications
Table 2: Drivers in Osteoarthritis Pain Drugs Market
Table 3: Restraints Osteoarthritis Pain Drugs Market
Table 4: Opportunity in Osteoarthritis Pain Drugs Market
Table 5: Comparion of Alternative and Osteoarthritis Pain Drugs
Table 6: Osteoarthritis Pain Drugs Raw Materials Key Suppliers List
Table 7: Osteoarthritis Pain Drugs Distributors List
Table 8: Osteoarthritis Pain Drugs Major Buyers in Application One
Table 9: Osteoarthritis Pain Drugs Major Buyers in Application Two
Table 10: Osteoarthritis Pain Drugs Major Buyers in Application Three
Table 11: Global Osteoarthritis Pain Drugs Sales (K Units) by Type 2016-2021
Table 12: Global Osteoarthritis Pain Drugs Sales Market Share by Type 2016-2021
Table 13: Global Osteoarthritis Pain Drugs Revenue (Million USD) by Type 2016-2021
Table 14: Global Osteoarthritis Pain Drugs Revenue Market Share by Type 2016-2021
Table 15: Global Osteoarthritis Pain Drugs Price by Type 2016-2021
Table 16: Global Osteoarthritis Pain Drugs Sales (K Units) by Application 2016-2021
Table 17: Global Osteoarthritis Pain Drugs Sales Market Share by Application 2016-2021
Table 18: Global Osteoarthritis Pain Drugs Revenue (Million USD) by Application 2016-2021
Table 19: Global Osteoarthritis Pain Drugs Revenue Market Share by Application 2016-2021
Table 20: Global Osteoarthritis Pain Drugs Price by Application 2016-2021
Table 21: Global Osteoarthritis Pain Drugs Sales (K Units) by Region 2016-2021
Table 22: Global Osteoarthritis Pain Drugs Sales Market Share by Region 2016-2021
Table 23: Global Osteoarthritis Pain Drugs Revenue (Million USD) by Region 2016-2021
Table 24: Global Osteoarthritis Pain Drugs Revenue Market Share by Region 2016-2021
Table 25: North America Osteoarthritis Pain Drugs Sales (K Units) by Country 2016-2021
Table 26: North America Osteoarthritis Pain Drugs Sales Market Share by Country 2016-2021
Table 27: North America Osteoarthritis Pain Drugs Revenue (Million USD) by Country 2016-2021
Table 28: North America Osteoarthritis Pain Drugs Revenue Market Share by Country 2016-2021)
Table 29: Europe Osteoarthritis Pain Drugs Sales (K Units) by Country 2016-2021
Table 30: Europe Osteoarthritis Pain Drugs Sales Market Share by Country 2016-2021
Table 31: Europe Osteoarthritis Pain Drugs Revenue (Million USD) by Country 2016-2021
Table 32: Europe Osteoarthritis Pain Drugs Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Osteoarthritis Pain Drugs Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Osteoarthritis Pain Drugs Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Osteoarthritis Pain Drugs Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Osteoarthritis Pain Drugs Revenue Market Share by Country 2016-2021)
Table 37: South America Osteoarthritis Pain Drugs Sales (K Units) by Country 2016-2021
Table 38: South America Osteoarthritis Pain Drugs Sales Market Share by Country 2016-2021
Table 39: South America Osteoarthritis Pain Drugs Revenue (Million USD) by Country 2016-2021
Table 40: South America Osteoarthritis Pain Drugs Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Osteoarthritis Pain Drugs Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Osteoarthritis Pain Drugs Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Country 2016-2021)
Table 45 Zhejiang Chengyi Pharmaceutical Company Information
Table 46 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
Table 47 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 TEVA Company Information
Table 49 TEVA Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
Table 50 TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Taisho Pharmaceutical Company Information
Table 52 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
Table 53 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 SK Chemicals Company Information
Table 55 SK Chemicals Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
Table 56 SK Chemicals Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Sino Biopharmaceutical Company Information
Table 58 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
Table 59 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Seikagaku Corporation Company Information
Table 61 Seikagaku Corporation Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
Table 62 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Sanofi Company Information
Table 64 Sanofi Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
Table 65 Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Pfizer Company Information
Table 67 Pfizer Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
Table 68 Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Mylan Company Information
Table 70 Mylan Osteoarthritis Pain Drugs Product Portfolio, Specification and Application
Table 71 Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Osteoarthritis Pain Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Osteoarthritis Pain Drugs Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Osteoarthritis Pain Drugs Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Osteoarthritis Pain Drugs Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Osteoarthritis Pain Drugs Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Osteoarthritis Pain Drugs Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Application (2022-2027)
Tables and Figures
List of Figures
Figure 1: Osteoarthritis Pain Drugs Picture
Figure 2: Global Osteoarthritis Pain Drugs Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Osteoarthritis Pain Drugs Supply Chain Analysis
Figure 5: Osteoarthritis Pain Drugs Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Oral
Figure 7: Product Picture of Injection
Figure 8: Global Osteoarthritis Pain Drugs Sales Market Share by Type, 2020
Figure 9: Global Osteoarthritis Pain Drugs Revenue Market Share by Type, 2020
Figure 10: Osteoarthritis Pain Drugs in Medical Care
Figure 11: Global Osteoarthritis Pain Drugs Market: Medical Care 2016-2021
Figure 12: Osteoarthritis Pain Drugs in Personal Care
Figure 13: Global Osteoarthritis Pain Drugs Market: Personal Care 2016-2021
Figure 14: Global Osteoarthritis Pain Drugs Sales Market Share by Application, 2020
Figure 15: Global Osteoarthritis Pain Drugs Revenue Market Share by Application, 2020
Figure 16: Global Osteoarthritis Pain Drugs Sales Market Share by Region 2016-2021
Figure 17: Global Osteoarthritis Pain Drugs Revenue Market Share by Region 2016-2021
Figure 18: North America Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 19: North America Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 20: Europe Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 21: Europe Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 24: South America Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 25: South America Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 28: North America Osteoarthritis Pain Drugs Sales Market Share by Country, 2020
Figure 29: North America Osteoarthritis Pain Drugs Revenue Market Share by Country, 2020
Figure 30: United States Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 31: United States Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 32: Canada Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 33: Canada Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 35: Mexico Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 36: Europe Osteoarthritis Pain Drugs Sales Market Share by Country, 2020
Figure 37: Europe Osteoarthritis Pain Drugs Revenue Market Share by Country, 2020
Figure 38: Germany Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 39: Germany Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 40: France Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 41: France Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 42: UK Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 43: UK Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 44: Italy Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 45: Italy Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 46: Russia Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 46: Russia Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 47: Spain Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 48: Spain Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Osteoarthritis Pain Drugs Sales Market Share by Country, 2020
Figure 50: Asia Pacific Osteoarthritis Pain Drugs Revenue Market Share by Country, 2020
Figure 51: China Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 52: China Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 53: Japan Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 54: Japan Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 55: Korea Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 56: Korea Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 59: India Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 60: India Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 61: Australia Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 62: Australia Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 63: South America Osteoarthritis Pain Drugs Sales Market Share by Country, 2020
Figure 64: South America Osteoarthritis Pain Drugs Revenue Market Share by Country, 2020
Figure 65: Brazil Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 66: Brazil Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 68: Argentina Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 70: Colombia Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Country, 2020
Figure 73: Turkey Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 74: Turkey Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Osteoarthritis Pain Drugs Sales (K Units) Status 2016-2021
Figure 78: South Africa Osteoarthritis Pain Drugs Revenue (Million USD) Status 2016-2021
Figure 79: Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Revenue Market Share Globally (2019-2021)
Figure 80: TEVA Osteoarthritis Pain Drugs Revenue Market Share Globally (2019-2021)
Figure 81: Taisho Pharmaceutical Osteoarthritis Pain Drugs Revenue Market Share Globally (2019-2021)
Figure 82: SK Chemicals Osteoarthritis Pain Drugs Revenue Market Share Globally (2019-2021)
Figure 83: Sino Biopharmaceutical Osteoarthritis Pain Drugs Revenue Market Share Globally (2019-2021)
Figure 84: Seikagaku Corporation Osteoarthritis Pain Drugs Revenue Market Share Globally (2019-2021)
Figure 85: Sanofi Osteoarthritis Pain Drugs Revenue Market Share Globally (2019-2021)
Figure 86: Pfizer Osteoarthritis Pain Drugs Revenue Market Share Globally (2019-2021)
Figure 87: Mylan Osteoarthritis Pain Drugs Revenue Market Share Globally (2019-2021)
Figure 88: Mikasa Seiyaku Osteoarthritis Pain Drugs Revenue Market Share Globally (2019-2021)
Figure 89: Global Osteoarthritis Pain Drugs Sales (K Units) Forecast (2022-2027)
Figure 90: Global Osteoarthritis Pain Drugs Sales (K Units) Forecast (2022-2027)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets